Insider Buying: GILEAD SCIENCES, INC., Gilead Sciences, Inc. [GILD] 10% Owner invested 485,250 shares
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares valued at $368,790 were purchased by GILEAD SCIENCES, INC. on Apr 02 ’24. At $0.76 per share, GILEAD SCIENCES, INC. acquired 485,250 shares. The insider’s holdings grew […]
Truist’s latest rating for GILD stock
Gilead Sciences, Inc.’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $0.37 million on Apr 02 ’24. In the deal valued at $0.76 per share,485,250 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 7,345,473 shares worth roughly $491.78 million. Then, Parsey Merdad […]
Insider Buying: GILEAD SCIENCES, INC., Gilead Sciences, Inc. [GILD] 10% Owner invested 485,250 shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $368,790 were purchased by GILEAD SCIENCES, INC. on Apr 02 ’24. At $0.76 per share, GILEAD SCIENCES, INC. acquired 485,250 shares. The insider’s holdings grew to 7,345,473 shares […]
Gilead Sciences, Inc. (GILD) gets rating Downgrade from Truist
Gilead Sciences, Inc.’s recently made public that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $0.37 million on Apr 02 ’24. In the deal valued at $0.76 per share,485,250 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 7,345,473 shares worth roughly $497.66 million. Then, Parsey Merdad […]
A company insider recently bought 485,250 shares of Gilead Sciences, Inc. [GILD]. Should You Buy?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $368,790 were purchased by GILEAD SCIENCES, INC. on Apr 02 ’24. At $0.76 per share, GILEAD SCIENCES, INC. acquired 485,250 shares. The insider’s holdings grew to 7,345,473 shares […]
Analyzing Gilead Sciences, Inc. (GILD) After Recent Trading Activity
In a filing, Gilead Sciences, Inc. revealed its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $0.37 million on Apr 02 ’24. In the deal valued at $0.76 per share,485,250 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 7,345,473 shares worth roughly $509.92 million. Then, Parsey Merdad […]
Days-to-cover ratio for GILD declines to 2.6 due to decline in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at $368,790 were purchased by GILEAD SCIENCES, INC. on Apr 02 ’24. At $0.76 per share, GILEAD SCIENCES, INC. acquired 485,250 shares. The insider’s holdings grew to 7,345,473 shares […]
Truist downgrades Gilead Sciences, Inc. (GILD) rating to a Hold
Gilead Sciences, Inc.’s recently made public that its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.76 million. Then, Parsey Merdad sold […]
Gilead Sciences, Inc. [GILD] Insider Parsey Merdad sells 8,230 Shares – Latest Insider Activity
In a filing, Gilead Sciences, Inc. revealed its Chief Medical Officer Parsey Merdad unloaded Company’s shares for reported $0.6 million on Feb 29 ’24. In the deal valued at $72.74 per share,8,230 shares were sold. As a result of this transaction, Parsey Merdad now holds 92,706 shares worth roughly $6.73 million. Then, Parsey Merdad sold […]
ContextLogic (WISH) Failed To Perform Well On IPO, Airline Stocks Also Dropped For Low Recommendation,
On Wednesday, ContextLogic Inc (WISH) had a less flamboyant IPO than that of Airbnb Inc (ABNB) and DoorDash Inc (DASH). The parent company of online sales platform Wish, launched on Wednesday under the ticker “WISH” on the Nasdaq, lost ground for its first day of listing by dropping -16.4% to end the session at $20.05. […]
